Feature

Q&A: What to know about the new BA 2.86 COVID variant


 

The Centers for Disease Control and Prevention and the World Health Organization have dubbed the BA 2.86 variant of COVID-19 as a variant to watch.

So far, only 26 cases of “Pirola,” as the new variant is being called, have been identified: 10 in Denmark, four each in Sweden and the United States, three in South Africa, two in Portugal, and one each the United Kingdom, Israel, and Canada. BA 2.86 is a subvariant of Omicron, but according to reports from the CDC, the strain has many more mutations than the ones that came before it.

With so many facts still unknown about this new variant, this news organization asked experts what people need to be aware of as it continues to spread.

What is unique about the BA 2.86 variant?

“It is unique in that it has more than three mutations on the spike protein,” said Purvi S. Parikh, MD, an infectious disease expert at New York University’s Langone Health. The virus uses the spike proteins to enter our cells.

This “may mean it will be more transmissible, cause more severe disease, and/or our vaccines and treatments may not work as well, as compared to other variants,” she said.

What do we need to watch with BA 2.86 going forward?

“We don’t know if this variant will be associated with a change in the disease severity. We currently see increased numbers of cases in general, even though we don’t yet see the BA.2.86 in our system,” said Heba Mostafa, PhD, director of the molecular virology laboratory at Johns Hopkins Hospital in Baltimore.

“It is important to monitor BA.2.86 (and other variants) and understand how its evolution impacts the number of cases and disease outcomes,” she said. “We should all be aware of the current increase in cases, though, and try to get tested and be treated as soon as possible, as antivirals should be effective against the circulating variants.”

What should doctors know?

Dr. Parikh said doctors should generally expect more COVID cases in their clinics and make sure to screen patients even if their symptoms are mild.

“We have tools that can be used – antivirals like Paxlovid are still efficacious with current dominant strains such as EG.5,” she said. “And encourage your patients to get their boosters, mask, wash hands, and social distance.”

How well can our vaccines fight BA 2.86?

“Vaccine coverage for the BA.2.86 is an area of uncertainty right now,” said Dr. Mostafa.

In its report, the CDC said scientists are still figuring out how well the updated COVID vaccine works. It’s expected to be available in the fall, and for now, they believe the new shot will still make infections less severe, new variants and all.

Prior vaccinations and infections have created antibodies in many people, and that will likely provide some protection, Dr. Mostafa said. “When we experienced the Omicron wave in December 2021, even though the variant was distant from what circulated before its emergence and was associated with a very large increase in the number of cases, vaccinations were still protective against severe disease.”

Pages

Recommended Reading

What’s new in brain health?
MDedge Psychiatry
Even mild COVID is hard on the brain
MDedge Psychiatry
Negative expectations of COVID shots may amplify side effects
MDedge Psychiatry
Explanation proposed for long-COVID symptoms in the CNS
MDedge Psychiatry
Anxiety, your brain, and long COVID: What the research says
MDedge Psychiatry
Patients with post-COVID cognitive symptoms may have gliosis
MDedge Psychiatry
International rights group calls out United States for allowing hospitals to push millions into debt
MDedge Psychiatry
Agency issues advisory on mental health symptoms of long COVID
MDedge Psychiatry
Long COVID ‘brain fog’ confounds doctors, but new research offers hope
MDedge Psychiatry
Use of mental health services soared during pandemic
MDedge Psychiatry